Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Aug;22(2):231–236. doi: 10.1128/aac.22.2.231

Ribosomal resistance in the gentamicin producer organism Micromonospora purpurea.

W Piendl, A Böck
PMCID: PMC183717  PMID: 6927285

Abstract

The mechanism of resistance of the gentamicin-producing organism Micromonospora purpurea was analyzed. Determination of minimal inhibitory concentrations revealed high resistance to the 4,6-substituted deoxystreptamine aminoglycosides amikacin, gentamicin, kanamycin, netilmicin, sisomicin, and tobramycin and also to lividomycin A and hygromycin B, but susceptibility to streptomycin, dihydrostreptomycin, paromomycin, and neomycin during all phases of the growth cycle. The nonproducing, closely related Micromonospora melanosporea was susceptible to these compounds. In agreement with results from previous studies (R. Benveniste and J. Davies, Proc. Natl. Acad. Sci. U.S.A. 70:2276-2280, 1973), extracts from M. purpurea showed no activity of enzymes specifically modifying gentamicin. 70S ribosomes from M. purpurea but not from M. melanosporea were resistant to inhibition by gentamicin, kanamycin, tobramycin, and lividomycin in a polyuridylic acid-dependent polyphenylalanine synthesis system and susceptible to those compounds which were inhibitory in vivo. The former antibiotics were also unable to induce misreading. Subunit exchange experiments between M. purpurea and M. melanosporea showed that the main site for inhibition and induction of misreading is the 30S subunit (up to gentamicin concentrations of 10 micrograms/ml).

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad M. H., Rechenmacher A., Böck A. Interaction between aminoglycoside uptake and ribosomal resistance mutations. Antimicrob Agents Chemother. 1980 Nov;18(5):798–806. doi: 10.1128/aac.18.5.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aszalos A., Frost D. Thin-layer chromatography of antibiotics. Methods Enzymol. 1975;43:172–213. doi: 10.1016/0076-6879(75)43084-1. [DOI] [PubMed] [Google Scholar]
  3. Benveniste R., Davies J. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2276–2280. doi: 10.1073/pnas.70.8.2276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bryan L. E., Van Den Elzen H. M. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother. 1977 Aug;12(2):163–177. doi: 10.1128/aac.12.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buckel P., Buchberger A., Böck A., Wittmann H. G. Alteration of ribosomal protein L6 in mutants of Escherichia coli resistant to gentamicin. Mol Gen Genet. 1977 Dec 14;158(1):47–54. doi: 10.1007/BF00455118. [DOI] [PubMed] [Google Scholar]
  6. Campuzano S., Vázquez D., Modolell J. Functional interaction of neomycin B and related antibiotics with 30S and 50S ribosomal subunits. Biochem Biophys Res Commun. 1979 Apr 13;87(3):960–966. doi: 10.1016/0006-291x(79)92050-3. [DOI] [PubMed] [Google Scholar]
  7. Choi E. C., Nishimura T., Tanaka N. Mutational alterations of either large or small ribosomal subunit for the kanamycin resistance. Biochem Biophys Res Commun. 1980 Jun 16;94(3):755–762. doi: 10.1016/0006-291x(80)91299-1. [DOI] [PubMed] [Google Scholar]
  8. Cundliffe E., Thompson J. Ribose methylation and resistance to thiostrepton. Nature. 1979 Apr 26;278(5707):859–861. doi: 10.1038/278859a0. [DOI] [PubMed] [Google Scholar]
  9. Davies J., Smith D. I. Plasmid-determined resistance to antimicrobial agents. Annu Rev Microbiol. 1978;32:469–518. doi: 10.1146/annurev.mi.32.100178.002345. [DOI] [PubMed] [Google Scholar]
  10. Demain A. L. How do antibiotic-producing microorganisms avoid suicide? Ann N Y Acad Sci. 1974 May 10;235(0):601–612. doi: 10.1111/j.1749-6632.1974.tb43294.x. [DOI] [PubMed] [Google Scholar]
  11. Gesteland R. F. Isolation and characterization of ribonuclease I mutants of Escherichia coli. J Mol Biol. 1966 Mar;16(1):67–84. doi: 10.1016/s0022-2836(66)80263-2. [DOI] [PubMed] [Google Scholar]
  12. Geyl D., Böck A., Isono K. An improved method for two-dimensional gel-electrophoresis: analysis of mutationally altered ribosomal proteins of Escherichia coli. Mol Gen Genet. 1981;181(3):309–312. doi: 10.1007/BF00425603. [DOI] [PubMed] [Google Scholar]
  13. Graham M. Y., Weisblum B. 23S ribosomal ribonucleic acid of macrolide-producing streptomycetes contains methylated adenine. J Bacteriol. 1979 Mar;137(3):1464–1467. doi: 10.1128/jb.137.3.1464-1467.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haas M. J., Dowding J. E. Aminoglycoside-modifying enzymes. Methods Enzymol. 1975;43:611–628. doi: 10.1016/0076-6879(75)43124-x. [DOI] [PubMed] [Google Scholar]
  15. Hotta K., Yamamoto H., Okami Y., Umezawa H. Resistance mechanisms of kanamycin-, neomycin-, and streptomycin-producing streptomycetes to aminoglycoside antibiotics. J Antibiot (Tokyo) 1981 Sep;34(9):1175–1182. doi: 10.7164/antibiotics.34.1175. [DOI] [PubMed] [Google Scholar]
  16. Kühberger R., Piepersberg W., Petzet A., Buckel P., Böck A. Alteration of ribosomal protein L6 in gentamicin-resistant strains of Escherichia coli. Effects on fidelity of protein synthesis. Biochemistry. 1979 Jan 9;18(1):187–193. doi: 10.1021/bi00568a028. [DOI] [PubMed] [Google Scholar]
  17. Le Goffic F., Capmau M. L., Tangy F., Caminade E. Have deoxystreptamine aminoglycoside antibiotics the same binding site on bacterial ribosomes? J Antibiot (Tokyo) 1980 Aug;33(8):895–899. doi: 10.7164/antibiotics.33.895. [DOI] [PubMed] [Google Scholar]
  18. Piwowarski J. M., Shaw P. D. Streptomycin resistance in a streptomycin-producing microorganism. Antimicrob Agents Chemother. 1979 Aug;16(2):176–182. doi: 10.1128/aac.16.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rosset R., Gorini L. A ribosomal ambiguity mutation. J Mol Biol. 1969 Jan 14;39(1):95–112. doi: 10.1016/0022-2836(69)90336-2. [DOI] [PubMed] [Google Scholar]
  20. Sugiyama M., Mochizuki H., Nimi O., Nomi R. Mechanism of protection of protein synthesis against streptomycin inhibition in a producing strain. J Antibiot (Tokyo) 1981 Sep;34(9):1183–1188. doi: 10.7164/antibiotics.34.1183. [DOI] [PubMed] [Google Scholar]
  21. Traub P., Nomura M. Streptomycin resistance mutation in Escherichia coli: altered ribosomal protein. Science. 1968 Apr 12;160(3824):198–199. doi: 10.1126/science.160.3824.198. [DOI] [PubMed] [Google Scholar]
  22. Yamamoto H., Hotta K., Okami Y., Umezawa H. Ribosomal resistance of an istamycin producer, Streptomyces tenjimariensis, to aminoglycoside antibiotics. Biochem Biophys Res Commun. 1981 Jun 16;100(3):1396–1401. doi: 10.1016/0006-291x(81)91979-3. [DOI] [PubMed] [Google Scholar]
  23. Zierhut G., Piepersberg W., Böck A. Comparative analysis of the effect of aminoglycosides on bacterial protein synthesis in vitro. Eur J Biochem. 1979 Aug 1;98(2):577–583. doi: 10.1111/j.1432-1033.1979.tb13219.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES